Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner

sonderdruck aus: Drug testing and analysis | 2022

von Giorgetti, A. | Brunetti, P. | Pelotti, S. | +1

Investigation of the [my] and [kappa]‐opioid receptor activation by eight new synthetic opioids using the [35S]‐GTPγS assay: U‐47700, isopropyl U‐47700, U‐49900, U‐47931E, N‐methyl U‐47931E, U‐51754, U‐48520 and U‐48800

sonderdruck aus: Drug testing and analysis | 2022

von Otte, L. | Wilde, M. | Auwärter, V. | +1

Separating the wheat from the chaff: observations on the analysis of lysergamides LSD, MIPLA, and LAMPA

sonderdruck aus: Drug testing and analysis | 2022

von Brandt, S. | Kavanagh, P. | Westphal, F. | +7

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD

sonderdruck aus: Drug testing and analysis | 2022

von Brandt, S. | Kavanagh, P. | Westphal, F. | +6

Cumyl‐CBMICA: a new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain

sonderdruck aus: Drug testing and analysis | 2021

von Halter, S. | Pulver, B. | Wilde, M. | +8

A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: comparing prison and general populations

sonderdruck aus: Drug testing and analysis | 2021

von Norman, C. | Halter, S. | Haschimi, B. | +8

New synthetic cannabinoids carrying a cyclobutyl methyl side chain: human phase‐I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA

sonderdruck aus: Drug testing and analysis | 2021

von Haschimi, B. | Grafinger, K. | Pulver, B. | +6

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

sonderdruck aus: Drug testing and analysis | 2021

von Grafinger, K. | Vandeputte, M. | Cannaert, A. | +9

Impact of legislation on NPS markets in Germany - the rise and fall of 5F‐ADB

sonderdruck aus: Drug testing and analysis | 2020

von Halter, S. | Haschimi, B. | Mogler, L. | +1

Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration

sonderdruck aus: Drug testing and analysis | 2020

von Grumann, C. | Henkel, K. | Brandt, S. | +3